American Association for the Study of Liver Diseases and Society on Liver Disease in Africa Community Conversation: Drug-Induced Liver Injury in Africa

Description

This interactive, joint AASLD and Society on Liver Disease in Africa (SOLDA) community conversation explores the global epidemiology of DILI and regional differences in its etiology. Needs associated with DILI and associated registries are identified. Through case presentations, panelists illustrate unique features of etiologies of DILI in Africa and highlight differences in diagnostic strategies and management. Presenters also review DILI survey data from Africa and identify DILI-related research gaps. The session aims to formulate strategies to overcome DILI managment challenges and advance DILI-related research in Africa. 

 

Presentations

9:45 AM - 9:50 AM
Nov 08 2025
Washington, D.C.

Introduction to American Association for the Study of Liver Diseases and Society on Liver Disease in Africa Community Conversation

Maurizio Bonacini, MD, FAASLD, Moderator
Drug-Induced Liver Injury
9:50 AM - 10:02 AM
Nov 08 2025
Washington, D.C.

Global Drug-Induced Liver Injury Registries: Differences, Similarities, and Needs

Lily Dara, MD, Presenter
Drug-Induced Liver Injury
10:02 AM - 10:14 AM
Nov 08 2025
Washington, D.C.

Pharmacologist Perspective

Wendy CW Spearman, MBChB, MMed, PhD, FCP(SA), FRCP(London), Presenter
Drug-Induced Liver Injury
10:14 AM - 10:26 AM
Nov 08 2025
Washington, D.C.

Research Gaps: Pan-African Database Creation

Patricia Denise D Jones, MD, MSCR, Presenter
Drug-Induced Liver Injury

Objectives

  • Summarize global differences in the epidemiology of DILI.
  • Describe current research gaps in DILI in Africa and strategies to address these gaps.
  • Review strategies to overcome management challenges in DILI.